The Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives, established in Denmark in 1924. Our vision is to improve people’s health and contribute to the sustainability of society and the planet. Through strategic grant giving, partnerships, and long-term investments, the Foundation seeks to generate impact that benefits both current and future generations. Community guidelines We welcome dialogue on our channels and value respectful engagement. However, we reserve the right to remove comments that are offensive, racist, sexist, discriminatory, spam, or otherwise inappropriate. Repeated violations may result in being blocked from our channels.
市場タイムラインとシグナルフィードを解放
過去 90 日間に 162 件のシグナル。
この企業が各市場へ参入した順序 — 古い順から新しい順へ
登録してシグナルフィードをすべて表示
Novo Nordisk Foundation の海外展開を競合と比較
Novo Nordisk Foundation自社バーは比較対象企業間の相対的な規模を示します。
列5| 企業 | 市場 | 新規市場 | モメンタム | アクティビティ | 拡大スコア |
|---|---|---|---|---|---|
 Novo Nordisk Foundation自社 | 4 | 0 | -72% | 162 | 11 |
Senior Digital Workplace Manager (Maternity Cover)
求人を見るGentofte, Capital Region of Denmark, Denmark · 先週
Kontorelever
求人を見るGentofte, Capital Region of Denmark, Denmark · 3週間前
Student Assistant, Public Affairs
求人を見るGentofte, Capital Region of Denmark, Denmark · 3週間前
We’re launching a new roadmap to help unlock the potential of regenerative medicine in Europe. Based on a major analysis, it sets out what it will take to move from strong science to real-world therapies that treat or even cure disease.Today, Europe has the scientific foundations to lead globally. But too often, new knowledge isn’t translated into startups, clinical programmes, and approved treatments.We commissioned an analysis of Europe’s regenerative medicine landscape to better understand wh ...
終了
Novo Nordisk Foundation and Global Health EDCTP3 launch partnership to advance global health research - Novo Nordisk Fonden
終了
From foundational mRNA breakthroughs to unlocking the genetic mysteries of rare diseases, recipients of the Novo Nordisk Foundation Prize for Biomedicine don’t just study human health - they revolutionize it.This prestigious award honors outstanding scientists whose pioneering research has led to major medical breakthroughs and life-saving clinical applications.If you know a visionary scientist whose work is fundamentally shifting the paradigm of biomedicine, their contributions deserve the glob ...
終了INTREPIDアライアンスは、14の高リスクウイルスファミリーのうち6つで8つのウイルス疾患のみが臨床試験中であり、3つのファミリーでは抗ウイルス薬開発がないとパンデミック準備の重大なギャップを報告。
ノボノルディスク財団がCardioMetabolic Bridgeを立ち上げ、資金提供と指導により学術研究と治療開発を橋渡しし、心臓代謝疾患の創薬を加速する汎欧州イニシアチブを開始。
レネ・B・オッダーシェーデ率いるノボノルディスク財団は、医療とドラッグディスカバリーのための量子コンピューティングに投資し、約10年の長期的視点を持っています。
認証済みメールと直通電話を解放
無料 · カード不要
Novo Nordisk Foundation の事業、市場、成長シグナルに関する簡潔な回答。
© 2026 Pubrio. 無断転載を禁じます。
